Alzheimer’s Breakthrough: FDA Approves New Treatment: Scientists Hail ‘Moment We’ve All Been Waiting For’
US authorities have given the green light to a new drug against Alzheimer’s disease, expanding the treatment options available to people in the early stages of brain decline. The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s donanemab. The drug is sold under the brand name Kisunla. This comes just weeks after a … Read more